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Abstract
Ticks are serious haematophagus arthropod pests and are only second to mosquitoes as vectors of diseases of humans and
animals. The salivary glands of the slower feeding hard ticks such as Haemaphysalis longicornis are a rich source of bioactive
molecules and are critical to their biologic success, yet distinct molecules that help prolong parasitism on robust
mammalian hosts and achieve blood-meals remain unidentified. Here, we report on the molecular and biochemical features
and precise functions of a novel Kunitz inhibitor from H. longicornis salivary glands, termed Haemangin, in the modulation
of angiogenesis and in persistent blood-feeding. Haemangin was shown to disrupt angiogenesis and wound healing via
inhibition of vascular endothelial cell proliferation and induction of apoptosis. Further, this compound potently inactivated
trypsin, chymotrypsin, and plasmin, indicating its antiproteolytic potential on angiogenic cascades. Analysis of Haemangin-
specific gene expression kinetics at different blood-feeding stages of adult ticks revealed a dramatic up-regulation prior to
complete feeding, which appears to be functionally linked to the acquisition of blood-meals. Notably, disruption of
Haemangin-specific mRNA by a reverse genetic tool significantly diminished engorgement of adult H. longicornis, while the
knock-down ticks failed to impair angiogenesis in vivo. To our knowledge, we have provided the first insights into
transcriptional responses of human microvascular endothelial cells to Haemangin. DNA microarray data revealed that
Haemangin altered the expression of 3,267 genes, including those of angiogenic significance, further substantiating the
antiangiogenic function of Haemangin. We establish the vital roles of Haemangin in the hard tick blood-feeding process.
Moreover, our results provide novel insights into the blood-feeding strategies that enable hard ticks to persistently feed and
ensure full blood-meals through the modulation of angiogenesis and wound healing processes.
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Introduction
Angiogenesis or neovascularization, the formation of new blood
vessels from pre-existing ones, is involved in a variety of
physiological processes, such as corpus luteum formation,
embryonic development, and wound healing [1,2]. Also, angio-
genesis plays a vital role in the development and progression of
various pathological conditions, including rheumatoid arthritis,
diabetic retinopathy, and tumor metastasis [3]. The process of
angiogenesis involves activation and release of angiogenic factors,
release of proteolytic enzymes to degrade extracellular matrix
protein (ECM), migration and proliferation of endothelial cells,
and microvessel formation [4]. Pericellular proteinases, comprised
of membrane-type matrix metalloproteinases (MT-MMPs), serine
proteinases (SPs), and membrane-bound aminopeptidases, are
known to play key roles in angiogenesis [5].
The proteinase inhibitors of SPs belonging to the Kunitz, Kazal,
a-macroglobulin, and serpin families play critical roles in
physiological and pathophysiological states such as coagulation,
intravascular fibrinolysis, wound healing, angiogenesis, and tumor
metastasis [6,7]. The best studied serine proteinase inhibitors
(SPIs) to date in angiogenesis, tumor invasion, and metastasis are
the plasminogen activator inhibitor-1 (PAI-1), PAI-2 [8], and
maspin [9]. Kunitz-type SPIs such as tissue factor pathway
inhibitor (TFPI) inhibit the proliferation of basic fibroblast growth
factor (bFGF)-induced endothelial cells (ECs) in addition to their
inhibitory activity against tissue factor–mediated blood coagula-
tion cascade [10]. Snake venoms contain many unique proteins,
including Kunitz-type SPIs [11]. These Kunitz proteins are potent
inhibitors of trypsin, chymotrypsin, kallikrein, and plasmin;
however, little is known about their physiologic roles in
angiogenesis and angiogenesis-dependent diseases such as cancer.
Hard ticks are notorious ectoparasites that feed on blood for
quite a long period (e.g., 10 days or more) in contrast to fast-feeder
soft ticks, which usually feed for an hour [12]. Tick feeding is a
complex process and involves severe tissue damage caused by the
probing actions of barbed mouthparts and release of salivary
secretions to the feeding lesions, leading to host’s haemostatic,
inflammatory, and immune responses. However, despite the host’s
armoury of rejection mechanisms, the ticks manage to remain
attached and achieve engorgement [12,13]. Increasing evidence
suggests that success in blood-feeding relies on a pharmacy of
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has reported that the saliva of the hard tick Ixodes scapularis is a
negative modulator of angiogenesis and wound healing [15],
though the specific molecular component(s) is yet to be identified.
Moreover, the implications of hard-tick-modulated angiogenesis
and wound healing in persistent blood-feeding remain unknown.
To this end, we have looked for a novel salivary-specific
molecule(s) of interest in the hard tick Haemaphysalis longicornis.
We have selected a full-length cDNA that shows moderate
sequence homologies with Kunitz-type proteinase inhibitors from
the SG-specific expressed sequence tag (EST) library of adult
female H. longicornis [16] for its functional analysis. Here, we show
that an Escherichia coli–expressed recombinant protein, herein
called Haemangin, inhibits trypsin, chymotrypsin, and plasmin.
Also, we provide novel evidence that this Haemangin-like
modulatory protein is the key to the modulation of angiogenesis
and angiogenesis-dependent wound healing during persistent
blood-feeding and is vital for hard ticks in achieving host blood-
meals.
Results
Molecular Characterization of Haemangin
The composite full-length Haemangin cDNA sequence was 583
nucleotides long with a single open reading frame (ORF) of 363
bases. The ORF coded for a protein of 120 amino acids, including
a signal peptide of 19 residues (data not shown). The putative
mature protein has a molecular mass of 14,157 Da and an
isoelectric point (pI) of 10.65. The deduced protein has three
potential N-glycosylation sites. The unique primary structure of
the predicted protein consists of 10 cysteines forming 5 disulfide
bonds, a lysine- and histidine-rich carboxy terminus, and a single
Kunitz-like inhibitory domain that belongs to bovine pancreatic
trypsin inhibitor (BPTI)/Kunitz family of SPI, as detected with
Scan-Prosite program. A BLASTX analysis of the translated
product deduced from the ORF revealed that Haemangin shares
the greatest sequence identity (56%) with kalicludine 1, a K
+
channel inhibitor that belongs to the BPTI/Kunitz family of SPI,
obtained from the toxin of Anemonia sulcata (accession number
AAB35413). Haemangin also shares 51% sequence identity with
venom trypsin inhibitor isolated from the venom of Naja naja
(P20229), 49% with isoinhibitor K, a trypsin-kallikrein inhibitor K
from Helix promatica (P00994), 48% with TFPI from Homo sapiens
(AA089075), and 47% with venom basic protease inhibitor I of
Vipera ammodytes ammodytes (P00992). A comparison of the deduced
amino acid sequence of Haemangin with those of venom basic
proteinase inhibitors belonging to the BPTI/Kunitz family of SPIs
is shown (Figure 1A). Alignment data revealed that out of 5
disulfide bonds, 3 were conserved. The predicted signal peptides,
however, were not conserved. Phylogenetic data revealed that
Haemangin within the BPTI/Kunitz family of SPIs forms a
separate single cluster and is distantly related to Kunitz-type
inhibitors of snake-venom origin (data not shown).
Haemangin-specific transcript profiling at different blood-
feeding stages was analyzed by quantitative RT-PCR. Data
revealed that the target transcript was up-regulated as blood-
feeding progressed. A dramatic increase of Haemangin expression
was observed at 96 h of blood-feeding prior to acquisition of a full
blood-meal, which then sharply declined to a minimal level (data
not shown), indicating that Haemangin plays a role in the
acquisition of blood-meals.
The endogenous expression of Haemangin in SGs of a partial-
fed adult H. longicornis was shown to be localized in the salivary
acini by immunofluorescence staining (Figure 1B, left panel), but
was not detected in the SGs treated with pre-immune mouse sera
(Figure 1B, right panel).
Inhibition of Vascular Sprouting in Chick Aorta
A chick aortic ring assay was employed to examine whether
Haemangin inhibited angiogenesis in vitro. The absence of
Haemangin (control) allowed the formation of dense vascular
sprouts in aortic ring explants, while its presence (,500 nM)
potently inhibited vascular sprouting in a dose-dependent manner
(Figure 2A). HlSGE (,500 mg/ml) also strongly inhibited vascular
sprouting in a dose-response manner. The IC50 for Haemangin
and HlSGE was 100.81 nM and 129.63 mg/ml, respectively. A
dose-dependent inhibition curve of vascular sprouting is shown
(Figure 2B). We also observed that transfected E. coli lysate
(,100 ml/well) but not non-transfected E. coli lysate (,100 ml/
well) exerted an inhibitory activity (data not shown). Addition of
rTpx (500 nM) did not show any inhibitory effect on vascular
sprouting (Figure 2A). OmSGE (,500 mg/ml) completely failed to
inhibit vascular sprouting (Figure 2A).
Inhibition of Capillary Tube Formation
To further evaluate the potential of Haemangin in inhibiting
angiogenesis, we used human umbilical vein endothelial cells
(HUVECs) in a 96-well plate to examine Matrigel-induced
morphogenic differentiation of ECs into capillary-like tubes. Data
revealed that in the absence of Haemangin, HUVECs were
rapidly organized, forming a number of well-defined capillary-like
structures in Matrigel (Figure 3A). The presence of Haemangin
(,250 nM) strikingly inhibited tube formation. HlSGE (,200 mg/
ml) also inhibited tube formation in a dose-dependent manner.
Tube formation was also inhibited by transfected E. coli lysate
(,100 ml/well), but not by non-transfected E. coli lysate (,100 ml/
well) (data not shown) or by rTpx (250 nM). Of interest, OmSGE
(,200 mg/ml) did not inhibit tube formation. Dose-dependent
inhibition curves of tube formation are shown in Figure 3B. The
IC50 for Haemangin and HlSGE was 55.82 nM and 20.13 mg/ml,
respectively.
Author Summary
Ticks are notorious ectoparasites that exclusively feed on a
host’s blood for a period of 10 days or longer. Upon blood-
feeding, an adult female tick gains 100–200 times its body
weight compared to its pre-feeding stage. Despite the
host’s armoury of rejection mechanisms, ticks manage to
remain attached until a full blood-meal is ensured. The
molecular machineries that make the tick a success with its
feeding, however, remain unknown. We demonstrate that
the Kunitz-like protein Haemangin, identified from the
salivary glands of the tick Haemaphysalis longicornis, plays
vital roles in blood-feeding success. Using both cell- and
chick embryo–based bioassays, we have shown that
Haemangin efficiently disrupted angiogenesis and wound
healing processes, enabling ticks to remain attached and
allowing persistent feeding. Additionally, in a rabbit model,
we reveal that an elevated expression of Haemangin is
associated with the acquisition of full blood-meals.
Importantly, Haemangin-knockdown ticks fail to prevent
angiogenesis in the host’s tissues and consequently
achieve only a poor blood-meal as compared to normal
ticks. We conclude that Haemangin is vital for ticks’
survival and can be a novel therapeutic target against ticks
and tick-borne diseases, including tumor angiogenesis.
Haemangin Assists in Tick Feeding
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Haemangin distinctly abolished angiogenesis from the preexist-
ing blood vessels, while chick chorioalantoic membranes (CAMs)
treated with PBS alone revealed normal angiogenesis (Figure 4A).
HlSGE also inhibited angiogenesis in CAMs. Data on quantitative
analysis showed that Haemangin at 500 ng/disc and HlSGE at
2.5 mg/disc inhibited approximately 80% and 72% neovascular-
ization, respectively (Figure 4B).
Inhibition of Cell Proliferation and Wound Healing
Haemangin potently blocked proliferation of HUVECs in a
dose-dependent manner with an IC50 of 20.07 nM (Figure 5A).
Consistent results were obtained with HlSGE with an IC50 of
10.11 mg/ml (Figure 5A). The cell cytotoxicity effect of both
Haemangin and HlSGE was determined by measuring the lactate
dehydrogenase (LDH) activity. Neither Haemangin nor HlSGE
showed any cytotoxic effect at concentrations used for cell
proliferation assays (data not shown), suggesting that Haemangin
is non-toxic to mammalian cells.
To investigate whether Haemangin-induced inhibition of cell
proliferation is associated with apoptosis, HUVECs were incubat-
ed with Haemangin and were stained with Hoechst 33258 for
observing changes characteristic of apoptosis. Haemangin mark-
edly induced apoptosis of HUVECs at a concentration of 250 nM
(Figure 5B). The nuclei of living cells stained with Hoechst 33258
are shown as intact, with smooth and regular contour, while the
apoptotic cells show shrinkage and rounding, with highly
condensed, marginated, and fragmented nuclei, which are the
hallmarks of apoptosis [17]. HlSGE also caused apoptosis at a
concentration of 25 mg/ml (Figure 5B). A DNA-ladder assay was
performed to detect the typical DNA ladder, which is the
characteristic of apoptotic cells [17]. DNA extracted from
Figure 1. Primary structure and expression of Haemangin. (A) Sequence alignment of Haemangin with other venom basic proteinase
inhibitors belonging to the BPTI/Kunitz family of SPIs. CLUSTALW (1.83) alignment of BPTI/Kunitz-type SPIs: Nn, N. naja (P20229); Pa, Pseudodechis
australis (AAT45402); Va, V. ammodytes ammodytes (P00992); Em, Eristocophis macmahonii (P24541); Hl, H. longicornis (AB434485). The signal peptides
are underlined. Identical amino acid residues are marked with asterisks. The six conserved cysteine residues are in bold with numbers. Dashes indicate
gaps inserted to optimize the alignment. (B) Endogenous expression of Haemangin in adult H. longicornis SGs by immunofluorescence. Freshly
obtained SGs of a partially fed adult tick were washed in 0.1% PBS-T, fixed in acetone, and incubated with primary anti-Haemangin antibody. FITC-
labeled goat anti-mouse IgG was used as a secondary antibody (left panel). H. longicornis SGs treated with mouse pre-immune sera are regarded as
control (right panel).
doi:10.1371/journal.ppat.1000497.g001
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laddering pattern of DNA fragmentation (Figure 5C).
We have hypothesized that hard ticks evolved novel strategies to
suppress wound healing to avoid rejection by the host. To test this
hypothesis, we examined the ability of Haemangin to thwart
wound healing using artificially created wounds in a monolayer of
HUVECs (Figure 5D). In the absence of Haemangin, wound
healing was completed within 12 h (Figure 5D). Notably,
Haemangin dose-dependently inhibited wound healing with an
IC50 of 49.49 nM (Figure 5E). Similar results were obtained with
HlSGE with an IC50 of 10.49 mg/ml (Figure 5E).
Inhibition of Serine Proteinases
Haemangin dose-dependently inhibited trypsin and chymotryp-
sin, showing maximum inhibition of 90% and 82% with an IC50 of
64.65 nM and 294.61 nM, respectively (Figure 6A). Haemangin
poorly inhibited elastase (21%) (Figure 6A). HlSGE also potently
inhibited the activity of trypsin and chymotrypsin and slightly
inhibited elastase by 77%, 78%, and 14%, respectively (Figure 6A).
The IC50 was 6.43 mg/ml and 51.71 mg/ml for trypsin and
chymotrypsin, respectively. Data on BSA proteolysis inhibition
assays showed that Haemangin inhibited BSA proteolysis by
trypsin and chymotrypsin in a dose-dependent fashion (Figure 6B).
Consistent results were obtained with HlSGE (Figure 6B).
Haemangin was able to efficiently stimulate degradation of both
the plasmin heavy and light chains during fibrinolysis (Figure 6C).
However, relatively little activity was detectable with HlSGE
(Figure 6C). To further evaluate whether Haemangin directly
inhibit plasmin activity, in vitro fibrin polymer lysis assays were
conducted. A fibrin polymer was initially prepared and then
fibrinolysis was initiated by the addition of plasmin in the absence
or presence of increasing concentrations of Haemangin. An
Figure 2. Inhibition of vascular sprout formation in chick aorta in vitro. (A) Chick aortic rings (,1.0 mm) obtained from 12-day-old embryos
were placed in a 96-well tissue culture plate coated with 20 ml Matrigel. Then, 100 ml of EBM-2 media supplemented with penicillin and streptomycin
was added, followed by the addition of an increasing concentration of Haemangin or HlSGE/OmSGE. The plate was incubated at 37uC and at 5% CO2.
Vessel sprout formation was observed for 3 days and images were taken (magnification6100). (B) Dose-dependent response curves. Data on vessel
sprout formation in the presence of an increasing concentration of Haemangin or HlSGE compared to media alone (control, 100%) are expressed as
percentages. Error bars indicate the standard error of the mean (n=5).
doi:10.1371/journal.ppat.1000497.g002
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proceeded (data not shown), and reached a maximum value when
a stable fibrin polymer was formed (Figure 6D). A plasmin-
induced fibrinolysis yielded a clear suspension of the fibrin
polymer and exhibited a decrease in turbidity (Figure 6D).
Haemangin strongly inhibited plasmin-dependent fibrinolysis
while HlSGE moderately blocked fibrinolytic activity of the added
plasmin (Figure 6D), suggesting that Haemangin is able to inhibit
the proteolytic activity of plasmin on cross-linked fibrin polymer.
Modulation of Gene Expression Profiles
An attempt was made to examine the global gene expression
profiles of HUVECs stimulated with Haemangin to gain a precise
understanding of the molecular signaling cascades that facilitate
feeding and engorgement of hard ticks. By comparing the
expression profiles between Haemangin-exposed and nonexposed
HUVECs, gene ontology data based on molecular functions
revealed a total of 506 responsive genes out of 35,000 genes
expressed on the microarray chips. Of 506 altered genes, 317 were
up-regulated and 189 were down-regulated genes (Figures S1 and
S2). On the other hand, gene ontology data based on biological
processes demonstrated a total of 2,761 induced genes, of which
2,199 genes were up-regulated and 562 were down-regulated
(Tables S1 and S2).
Modulation of Tick Blood-Feeding
To explore Haemangin’s function in vivo, adult H. longicornis
were allowed to feed on rabbits (Figure 7A). Tick feeding
progression and engorgement were monitored and transcriptional
responses at different feeding stages were analyzed by semi-
quantitative RT-PCR. Data were consistent with that of
quantitative RT-PCR (Figure 7B). Tick feeding progression is
summarized in Figure 7B. Haemangin expression was steadily up-
regulated with the progression of feeding, showing a dramatic peak
Figure 3. Inhibition of capillary tube formation in vitro. (A) HUVECs were seeded (7.5610
3 cells/well) into a 96-well tissue culture plate coated
with 50 ml Matrigel. Then, an increasing concentration of Haemangin or HlSGE/OmSGE was added. Cells were incubated in HUVEC growth medium at
37uC, 5% CO2. Tube formation was observed for 6 h and images were taken (magnification6100). (B) Dose-dependent response curves. Data on tube
formation in the presence of an increasing concentration of Haemangin or HlSGE compared to media alone (control, 100%) are expressed as
percentages. Error bars indicate the standard error of the mean (n=3).
doi:10.1371/journal.ppat.1000497.g003
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upon engorgement. Healing of the feeding wounds commenced
immediately after ticks dropped off the host (Figure 7C, left panel),
and completed within 10–14 days (Figure 7C, right panel).
To validate gene functions in vivo, an RNA interference (RNAi)
tool was employed using Haemangin-specific double-stranded
RNA (dsRNA). Data revealed very scanty expression of Hae-
mangin-specific mRNA upon feeding, indicating that gene
knockdown was successful (Figure 7D). Notably, knockdown ticks
completely failed to make blood pools by 72 h and achieved
significantly diminished engorgement by 144 h, while control ticks
become engorged by 120 h, as shown by engorged body weights of
32.89618.36 and 314.18663.17 mg (p,0.001), respectively
(Figure 7E). Histologically, knockdown tick-fed lesions showed
an increased neovascularization compared with controls, suggest-
ing a novel antiangiogenic role for Haemangin (Figure 7F).
Discussion
Prior studies suggest that slower feeding hard ticks heavily rely
on salivary molecules for acquisition of blood-meals [12,13,18].
Here, we report on a salivary Kunitz inhibitor of H. longicornis that
modulates angiogenesis and wound healing, enabling ticks to feed
and engorge. Furthermore, our results substantiate a diversified
role of Kunitz proteins in angiogenesis-dependent human diseases.
We have shown that Haemangin pronouncedly disrupted
angiogenesis through inhibition of EC proliferation and induction
of apoptosis. These observations conform to the report of
Francischetti et al. [15], who described similar roles for tick saliva,
suggesting that tick saliva has MP activity that may cause
inhibition of cell proliferation and induction of apoptosis, although
the salivary molecule(s) responsible for the inhibition of angiogen-
esis was not confirmed. Angiogenesis is dependent on fibrinolytic
MPs and plasmin, indicating that cleavage of fibrin is required for
angiogenic cascades [19,20]. Angiogenesis is characterized by EC
proliferation, migration, and capillary tube formation, and is
dependent on cell adhesion molecules and proteinases [19,21]. In
contrast, inhibition of cell proliferation and induction of apoptosis
are among the most effective means of disruption of angiogenesis.
Proteolytic degradation of ECM and the vascular basement
membrane, and remodeling of the ECM components is essentially
required to allow ECs to migrate into and invade the surrounding
stroma [5,22,23]. However, excessive degradation of ECM is
incompatible with efficient migration of EC [24]. It has been
anticipated that the maintenance of a certain degree of ECM
integrity is indeed essential for capillary morphogenesis [25]. We
hypothesized that Haemangin exerts an antiangiogenic function
through the inhibition of proteolytic cascades, although we cannot
rule out alternative roles, such as the inhibition of cell adhesion
mechanisms by inactivating angiogenic growth factors. Plasmin
cleaves fibrinogen and fibrin, and activates various MMPs. Once
activated, plasmin can act by itself on ECM proteins and activates
MMP-1, MMP-2, MMP-3, and MMP-9 [26,27]. Furthermore, in
addition to MT1-MMP, plasmin has been indicated to be involved
in endothelial tube formation in a fibrin matrix [19,20,28]. Of
note, the ECM is known to act as a sequestration for angiogenic
Figure 4. Inhibition of angiogenesis in CAM in vivo. (A) Thermanox discs, 13 mm in diameter, loaded either with PBS only or test compounds
(Haemangin 500 ng/embryo and HlSGE 2.5 mg/embryo) were applied to CAMs of 8-day-old chick embryos. After 48 h of incubation at 37uC, negative
or positive responses were assessed. Images were taken using a digital camera (Canon). (B) Quantification of inhibition of angiogenesis by
Haemangin and HlSGE. Numbers of vessels were from 7–12 CAMs in each group. **p,0.001 and *p,0.01 versus control. Error bars indicate the
standard error of the mean.
doi:10.1371/journal.ppat.1000497.g004
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3 cells/well) into a 96-well tissue culture plate and were
incubatedinHUVECgrowthmediumintheabsenceorpresenceofHaemanginorHlSGEat37uC,5%CO2for72 h.Thenumbersofcellsineachwellwere
determined afterthe additionofMTS solution,andinhibitionofcellproliferation(%ofcontrol) was then estimated. Error bars indicatethe standarderror
of the mean (n=3). (B)Inductionof apoptosisof ECs. HUVECs were seeded (1610
5 cells/well) into a 6-well tissue culture plate andwere incubated in the
absence or presenceof Haemangin (250 nM) or HlSGE (25 mg/ml) for 48 h as in (A). Cells were stained with Hoechst 33258 (magnification6200). (C)DNA
ladder formation in HUVECs. Cells were seeded (2.5610
5 cells/flask) into a T-25 tissue culture flask and were incubated in the absence or presence of
Haemangin (250 nM) or HlSGE (25 mg/ml) for 48 h as in (A). Cytoplasmic DNA was isolated and analyzed using 1% agarose gel electrophoresis. (D)
Inhibitionofwoundhealinginvitro.HUVECs wereseeded(1.25610
5 cells/well) intoa6-welltissuecultureplateandweregrowntoconfluency inHUVEC
growth medium. An increasing concentration of either Haemangin or HlSGE was added at the time of scratching, and the wound healing process was
observed for 12 h. Wounds were treated with Haemangin (150 nM) and HlSGE (50 mg/ml), respectively (magnification650). (E) Quantification of wound
reduction by Haemangin and HlSGE. Error bars indicate the standard error of the mean (n=3).
doi:10.1371/journal.ppat.1000497.g005
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PLoS Pathogens | www.plospathogens.org 7 July 2009 | Volume 5 | Issue 7 | e1000497Figure 6. Inhibition of serine proteinases. (A) Inhibition of hydrolytic activity of trypsin, chymotrypsin, and elastase on synthetic substrates.
Enzyme inhibition assays were performed using fluorogenic substrates by measuring the residual hydrolytic activity after pre-incubation with
increasing concentrations of Haemangin or HlSGE. The final concentrations of enzyme/substrate used were as follows: trypsin (5.6 nM)/Substrate
(10 mM), chymotrypsin (5 mM)/Substrate (10 mM), and elastase (51 nM)/Substrate (10 mM). Each enzyme was pre-incubated with an increasing
concentration of Haemangin at 37uC for 30 min. After pre-incubation of enzyme and inhibitor, appropriate fluorogenic substrate was added. The
total volume of reaction mixture was 200 ml in individual wells in 96-well flat bottomed plates. The residual enzyme activity was measured by reading
the fluorescence over time at excitation and emission wavelengths of 360 and 460 nm, respectively. PMSF was used as a positive control. Percent
inhibition by Haemangin is assessed by the following formula: % inhibition=(1–inhibited rate/uninhibited rate)6100. Error bars indicate the standard
error of the mean (n=3). (B) Inhibition of BSA proteolysis by trypsin and chymotrypsin. Proteolysis inhibition assays were done by pre-incubating the
enzymes with increasing concentration of Haemangin or HlSGE in 20 mM Tris-HCl (pH 8.0) in a total reaction mixture of 40 ml for 1 h at 37uC. Then,
BSA (500 mg/ml) was added to the inhibited and uninhibited enzymes (250 mg/ml) (control) and was further incubated overnight at 37uC. The
following morning, tryptic digests were electrophoresed in 12.5% SDS-PAGE under reducing condition. Molecular weight markers in kDa (lane M) are
shown on the left. (C) Effects of Haemangin on plasmin degradation during fibrinolysis. Fibrinogen (8 mM) and thrombin (0.83 NIH unit/ml) were
incubated in a buffer containing 50 mM Tris-HCl (pH 7.5), 100 mM NaCl, and 5 mM CaCl2 at 25uC for 30 min. After the fibrin was completely
polymerized, lysis of fibrin polymer was initiated by the addition of 20 mM plasminogen and 15 nM t-PA. Reactions were started in the absence or
presence of 200 nM (+) and 400 nM (++) Haemangin, and 150 mg/ml (+) and 300 mg/ml (++) HlSGE separately. The reaction mixtures were incubated
overnight at 25uC and were subjected to 8% SDS-PAGE under reducing condition. (D) Inhibition of plasmin-dependent fibrin polymer lysis.
Fibrinogen (8 mM) and thrombin (0.83 NIH unit/ml) were incubated in a buffer mentioned in (C). After fibrin polymerization was completed, a 100 ml
buffer alone or buffer containing plasmin (1.5 mM) without or with an increasing concentration of Haemangin or HlSGE was added to initiate
fibrinolysis. Error bars indicate the standard error of the mean (n=3).
doi:10.1371/journal.ppat.1000497.g006
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PLoS Pathogens | www.plospathogens.org 8 July 2009 | Volume 5 | Issue 7 | e1000497Figure 7. Haemangin’s function in blood-feeding in vivo. (A) A naı ¨ve rabbit’s ear as source of blood-meals. (B) Blood-feeding progression and
engorgement of adult H. longicornis. Semi-quantitative RT-PCR was performed. Expression of Haemangin-specific mRNA is shown. Arrows indicate
areas of blood pool. (C) A rabbit ear showing feeding wounds after the engorged ticks dropped off the ear (arrows; left panel) and repaired wounds
on day 10 post-dropping (arrowheads; right panel). (D) Gene silencing of Haemangin by RNA interference. Ticks were injected either with E. coli malE
dsRNA (control) or with Haemangin dsRNA. RT-PCR analysis was performed. Expression of Haemangin-specific mRNA is shown. b-actin is shown as an
internal control. (E) Effect of targeted gene silencing on blood-feeding by adult ticks. Images were captured at 72 h and 120 h post-feeding. Arrows
indicate areas of blood pool. (F) Effect of targeted gene silencing on angiogenesis in vivo. H&E- and silver nitrate–stained sections of a rabbit ear at
120 h tick post-feeding, revealing capillaries and venules (arrows) and area of blood pool (arrowheads) (magnification6100).
doi:10.1371/journal.ppat.1000497.g007
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(VEGF), bFGF, and transforming growth factor (TGF)-b1, which
can be released upon proteolytic degradation of the ECM [29],
suggesting that plasmin is critical for angiogenesis. Overall, our
data indicate that Haemangin-induced plasmin proteolysis plays
an important role in the inhibition of angiogenesis during blood-
feeding by hard ticks. For the suppression of tumor angiogenesis,
however, a tightly controlled proteolysis by proteinase inhibitors
(for example, uPA, plasmin, and probably MPs) is required [25].
Growth factors and their receptors are important mediators of
angiogenesis. The VEGF and bFGF are the two most potent
angiogenic factors that stimulate angiogenic cascades indepen-
dently [30]. Growth factors specifically bind and interact with their
receptors, which are all tyrosine kinases, present on the EC
surface, and in turn activate different signal transduction
pathways, leading to alteration of the transcription of genes
involved in cell migration, apoptosis, proliferation, and tube
formation [31]. Haemangin markedly induced apoptosis and
blocked EC proliferation directly, indicating that it may
simultaneously alter expression of angiogenic factors and/or
inactivate cell surface receptors. To explore molecular pathways
of Haemangin-modulated angiogenesis, high-throughput studies
were performed. Data revealed that Haemangin induces a wide
spectrum of genes associated with various biological processes,
including apoptosis, angiogenesis, and wound healing. An
enhanced expression of genes in response to cytokine and
chemokine activity, VEGF receptor activity, IL-6 receptor
binding, and receptor tyrosine kinase binding might reflect a
process of activation of inflammation and wounding, and higher
demand for cell proliferation and differentiation to supply oxygen
and nutrients for tissues in repairing process [32,33]. Haemangin
was also shown to repress a number of genes of angiogenic
significance. Extracellular signal–regulated kinase/mitogen-acti-
vated protein kinase (ERK/MAPK) signaling plays crucial roles in
diverse cellular functions, including cell proliferation, differentia-
tion, migration, and survival [34]. Also, FGF receptor signaling is
known to modulate a wide variety of cellular functions, including
epithelial cell morphogenesis [35]. Adenosine 39,59-cyclic mono-
phosphate (cAMP)-binding proteins directly activate Rap1, a
member of the Ras superfamily of small G proteins that, in turn,
stimulate and inhibit the activity of MAPK, such as B-Raf and
Raf-1, respectively, leading to altered activity of ERK/MAPK that
is critical for growth factor–induced cell proliferation and
angiogenesis [36,37]. Thus, Haemangin appears to utilize multiple
intracellular signaling pathways to negatively regulate angiogenesis
and angiogenesis-dependent wound healing.
Angiogenesis plays a central role in the wound healing process
[38]. Proteolytic degradation of ECM by serine proteinases,
particularly plasmin, and MMPs is crucial in this process [39]. EC
proliferation is one of the important steps in angiogenesis and is
critical for granulation tissue formation, a hallmark of wound
healing [40]. Data presented above strongly suggest that
Haemangin is capable of inhibiting different phases of wound
healing, from proteolytic degradation of ECM to EC proliferation
and differentiation, and eventually affects the tissue repair process.
This may likely slow tick rejection and favor feeding and
engorgement.
Salivary anticoagulants (Salp14 and its paralogs) and cysteine
protienase inhibitors in I. scapularis are reported to contribute to
blood-feeding success [41,42], although their roles in angiogenesis
and wound healing are still unclear. Of note, a dramatic
upregulation of Haemangin-specific mRNA prior to the acquisi-
tion of full blood-meals indicated its crucial role in blood-meal
acquisition. This finding, together with RNAi data, strongly
supports such a role for Haemangin. Interestingly, the fast-feeder
counterpart Ornithodoros moubata lacks both Haemangin-like Kunitz
inhibitor and antiangiogenic functions, and is similar to other fast-
feeder haematophagus arthropods, for example, mosquitoes and
sand flies, whose SGs do not affect ECs [15]. This may likely
explain the functional significance of Haemangin in blood-feeding
strategies and success by slower feeding arthropods like hard ticks.
In conclusion, these results show that unlike fast-feeder
arthropods, slow-feeder hard ticks evolve novel strategies to
remain attached on large mammalian counterparts and achieve
engorgement through the modulation of angiogenesis and wound
healing processes. Furthermore, the Haemangin-like modulatory
peptide(s) is considered vital for the hard tick’s survival and can be
a potential therapeutic target against ticks and tick-borne
pathogens, including tumor angiogenesis.
Materials and Methods
Ticks and Tick Salivary Glands
H. longicornis and O. moubata (soft tick) were maintained in the
Laboratory of Parasitic Diseases, National Institute of Animal
Health (NIAH), Japan. SGs were obtained from adult H. longicornis
at different blood-feeding stages. SGs from adult soft ticks were
collected after partial blood-feeding on rabbits. Animal experi-
mentation was done in accordance with the protocol approved by
the NIAH Animal Care and Use Committee.
Cloning and Sequencing of cDNA
Recently, our group generated a total of 8,000 ESTs from the
SGs cDNA libraries of adult H. longicornis [16]. Of these, a full-
length cDNA clone encoding a protein called Haemangin showing
moderate homologies with Kunitz-type inhibitors was selected for
this study. The BLAST program for alignment was used to
compare the Haemangin sequence with previously reported
sequences available in GenBank.
Recombinant Proteins
The coding region of the Haemangin gene including the signal
sequence was amplified by PCR. A sense primer (59-
GGAATTCCTCACTCCATGTTGTTATGTAA-39) containing
an EcoRI site upstream of the start codon and an antisense primer
(59-CCGAGCTCGAGACGAGAGCCATTTCGCCAACCA-39)
containing a XhoI site just downstream of amino acid residue were
used (Promega). The purified PCR product was inserted into the
EcoRI and XhoI sites of plasmid expression vector pTrcHisB
(Invitrogen). The resultant plasmid was transformed into E. coli
strain TOP10F9 (Invitrogen) cells and expressed as a fusion
protein. Recombinant proteins were produced and solubilized
under denaturing conditions using 20 mM sodium phosphate,
500 mM sodium chloride, and 8 M urea (pH 7.8), and then
purified by histidine binding affinity chromatography (Bio-Rad)
followed by dialysis against 20 mM Tris-HCl (pH 8.0) and
150 mM NaCl. The purity of Haemangin was judged by SDS-
PAGE. Protein concentrations were measured with the Micro
BCA Protein Assay Reagent (Pierce).
Immunofluorescence
SGs were washed in PBS containing 0.1% Tween 20 (PBS-T)
and were fixed in acetone. After fixation, they were blocked with
10% goat serum (Wako) for 1 h and were incubated with anti-
mouse IgG to Haemangin overnight. FITC-conjugated goat anti-
mouse IgG (Sigma) was used as a secondary antibody and the
fluorescence was visualized under a Leica microscope.
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Proteinase inhibition assays were performed by measuring the
residual hydrolytic activity after preincubation with Haemangin.
To detect the inhibitory activity of endogenous Haemangin,
soluble extracts of H. longicornis SG extract (HlSGE) were prepared
in 20 mM Tris-HCl (pH 8.0). The enzymes were preincubated
with Haemangin or HlSGE for 30 min at 37uC. Then,
appropriate substrates in a 200 ml reaction mixture consisting of
100 mM Tris-HCl (pH 8.0), 100 mM NaCl, and 20 mM CaCl2 in
a 96-well plate were added, followed by incubation for 1 h at
37uC. Fluorogenic substrates for trypsin (Boc-Gln-Ala-Arg-MCA)
(1 mM), chymotrypsin (Suc-Ala-Ala-Pro-Phe-MCA) (1 mM), and
elastase (Suc-Ala-Ala-Ala-MCA) (1 mM) (Peptide Institute Inc.)
were used. Substrate hydrolysis was monitored by measuring
excitation and emission wavelength at 360 nm and 460 nm,
respectively, over time. Percentage of inhibition by Haemangin of
enzyme activity was assessed by the following formula: %
inhibition=(1–inhibited rate/uninhibited rate)6100. Inhibitory
activity of Haemangin and HlSGE on BSA proteolysis by trypsin
and chymotrypsin was examined by pre-incubating the enzymes
with Haemangin or HlSGE in a total reaction mixture of 40 ml for
1 h at 37uC for inhibition. Then, BSA (500 mg/ml) was added to
inhibited and control (uninhibited) enzymes (250 mg/ml) and was
further incubated overnight at 37uC. The tryptic digests were then
analyzed by SDS-PAGE.
Chick Aortic Ring Assay
A chick aortic ring assay was performed [15]. A twelve-day-old
chick embryo was removed by cracking the egg; the thoracic cavity
was opened and the heart and aortic arch were carefully removed.
The aortic arch was cut into ,1.0-mm pieces. A 96-well tissue
culture plate was coated with 3 ml Matrigel/well (BD Biosciences)
and aortic rings were placed into the wells; they were then held in
place by overlaying 20 ml Matrigel/well. Then, 100 ml of EBM-2
(BD Biosciences) supplemented with antibiotics was added
followed by the addition of Haemangin or HlSGE/OmSGE. A
SG-specific recombinant protein from H. longicornis, peroxiredoxin
(rTpx) [43], served as a negative control. Formation of vascular
sprouts was observed for 3 days under a Leica microscope. A blind
observer scored the density of vessel sprouts by comparing
responses with media alone (control) to that observed with
Haemangin. Results were scored as (i) 100%, sprout formation
achieved with media alone (control); (ii) 75%, high levels of sprout
formation; (iii) 50%, moderate levels of sprout formation; (iv) 25%,
low levels of sprout formation; and (v) 10%, very low levels of
sprout formation.
CAM Assay
A chick chorioalantoic membrane (CAM) assay as an in vivo
model of angiogenesis was performed to determine the antiangio-
genic activity of Haemangin [44]. Haemangin or HlSGE in a total
volume of 20 ml was loaded onto Thermanox discs, 13 mm in
diameter (Nunc), and was applied to the CAM of 8-day-old
embryos. PBS was used as a control. After 48 h of incubation at
37uC, a negative or positive response was assessed by two
observers in a double-blind manner.
Cell Culture and Capillary Tube Formation Assay
HUVECs (Cell Applications, Inc.) were cultured in growth
medium at 37uC, 5% CO2 according to the manufacturer’s
instructions. Cells were incubated in T-25 tissue culture flasks to
.80% confluency. Trypsinization was performed using the
Subculturing Reagent Kit according to the manufacturer’s
instructions. Tube formation assay was performed in a 96-well
plate coated with 50 ml Matrigel [45]. After trypsinization,
HUVECs were seeded at 7.5610
3/well. Then, 100 ml/well
growth medium was added. Cells were grown in the absence or
presence of Haemangin or HlSGE/OmSGE at 37uC, 5% CO2.
Tube formation was observed for 6 h under a Leica microscope.
The number of tubes formed in individual wells was counted and
data were expressed as a percentage compared to control.
Cell Proliferation Assay
A cell proliferation assay was conducted using a cell prolifer-
ation assay kit (Promega) [46]. The 96-well plate was seeded with
HUVECs at 3610
3/well. Cells were grown in 150 ml growth
medium for 24 h at 37uC, 5% CO2. Then, medium was refreshed
and Haemangin or HlSGE was added. After 3 days incubation,
30 ml MTS solution was added to each well. The plate was further
incubated and the absorbance at 490 nm was measured using a
spectrophotometer (Spectra Fluor). Results were expressed as
percent inhibition of HUVEC proliferation in the presence of
Haemangin or HlSGE compared to 100% cell proliferation
achieved with growth medium alone. A cell cytotoxicity assay was
performed using Cytotoxicity Detection Kit
PLUS (LDH) (Roche) as
described by the manufacturer to determine the cytotoxic effect of
Haemangin or HlSGE, if any.
Apoptosis and Wound Healing Assay
Apoptosis was analyzed by Hoechst 33258 (Invitrogen) staining
and by DNA-ladder assay. Hoechst 33258 staining of cells was
performed by culturing HUVECs (1610
5 cells per well) onto glass
coverslips in a 6-well plate (Sumitomo Bakelite) in growth medium
at 37uC, 5% CO2. Cells were grown to 90% confluency. Then,
Haemangin or HlSGE was added to the wells and cells were
further incubated for 48 h at 37uC, 5% CO2. Cells were washed in
PBS, fixed in 4% paraformaldehyde for 15 min, and stained with
8 mg/ml Hoechst 33258 (Hoechst) in H2O for 10 min. Cells were
analyzed for nuclear morphologic changes using a Leica
microscope equipped with fluorescence, DAPI, and composite
filters (360/420 nm excitation and emission, respectively), and
images were taken using Leica FW4000 Software. The DNA-
ladder assay was carried out using the Apoptotic DNA Ladder Kit
(Roche). Cells were cultured in a T-25 tissue culture flask (2.5610
5
cells/flask) in the absence or presence of Haemangin or HlSGE for
48 h at 37uC, 5% CO2 as mentioned above. The total cytoplasmic
DNA was extracted from 2610
6 cells. Isolated DNA was analyzed
using 1% agarose gel electrophoresis. The wound healing assay
was performed in a 6-well plate [47]. HUVECs were seeded
(1.25610
5 cells/well) in 6-well plate and were grown at 37uC, 5%
CO2 to confluency. A wound was made by scratching a line across
the monolayer of cells with a sterile pipette tip. The width of the
cell-free gap was measured continuously under a Leica microscope
by using Leica Application Suite. The response of wound healing
was measured by the percentage reduction of the width of the
scratch.
Plasmin Inhibition Assay
Haemangin-stimulated plasmin degradation assay was per-
formed [48]. Fibrinogen (8 mM; Sigma) and thrombin (0.83 NIH
unit/ml; Sigma) were incubated in a 400 ml buffer containing
50 mM Tris-HCl (pH 7.5), 100 mM NaCl, and 5 mM CaCl2 at
25uC for 30 min. After the fibrin was completely polymerized, lysis
of fibrin polymer was then initiated by adding 100 ml of buffer
containing 20 mM plasminogen (Calbiochem) and 15 nM t-PA
(Calbiochem) in the absence or presence of Haemangin or HlSGE.
The reaction mixtures were then incubated overnight at 25uC and
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by Coomassie staining of the proteins. To further examine the
effect of Haemangin on fibrinolytic activity of plasmin, plasmin-
dependent fibrinolysis inhibition assays were performed at 25uCt o
monitor changes in turbidity at 450 nm [48]. Fibrin polymer was
prepared in a volume of 400 ml buffer and 1.5 mM plasmin (Sigma)
without or with Haemangin, or HlSGE was added to initiate
fibrinolysis. After the sample was incubated at 25uC for 12 h,
plasmin-dependent fibrinolysis was observed and turbidity as
function of plasmin was measured at an absorbance of 450 nm.
RNA Interference
RNAi studies were carried out using dsRNA [42]. The coding
sequenceofHaemanginwascloned intopBluescriptIISK+ plasmid
(Toyobo). The dsRNA complementary to the E. coli malE gene was
used as a negative control [49]. cDNA corresponding to malE
mRNA was synthesized and was cloned into pBluescript II SK+
plasmid using the oligonucleotides 59-CCGCTCGAGCGGTTAT-
GAAAATAAAAACAGGTGCA-39 and 59-GAATTCGCTTG-
TCCTGGAACGCTTTGTC-39 as forward and reverse primers,
respectively. The inserted sequences of Haemangin and malE were
amplified by PCR using the oligonucleotide T7 (59-GTAATAC-
GACTCACTATAGGGC-39) and CM0422 primers (59-GCG-
TAATACGACTCACTATAGGGAACAAAAGCTGGAGCT-39)
to attach T7 promoter recognition sites at both ends. The PCR
products were purified using a gel extraction kit (Qiagen). dsRNA
complementary to the DNA insert was synthesized by in vitro
transcription using T7 RNA polymerase (Promega). One micro-
gram each of Haemangin and malE dsRNA in 0.5 mlo fP B S
separately was injected into each unfed adult tick. Ticks were
allowed to rest for 24 h at 25uC prior to placement on the host [16].
Rabbit tissues were also processed for H&E and silver nitrate
staining.
RNA Extraction and RT-PCR Analysis
The total RNA from tick SGs was isolated using an RNAeasy
Mini Kit (Qiagen) and was submitted to reverse transcription (RT)
before PCR. cDNA was synthesized and was employed to perform
PCRs using either Haemangin-specific oligonucleotides (59-
CATTTCGCCAACCATCTTTC-39 and 59-TGACAGGTC-
CAGCAGCTATG-39) or oligonucleotides specific for b-actin.
Quantitative RT-PCR was done using LightCycler FastStart DNA
Master SYBR Green I (Roche) in a LightCycler 1.5 instrument
(Roche) [16].
RNA Extraction and Microarray Analysis
To perform oligonucleotide microarray analysis, HUVECs were
cultured in the absence (control) or presence of Haemangin
(100 nM) for 48 h as described above. Approximately 2610
6 cells
were harvested and the total RNA was extracted as described
above. The mRNAs were then prepared and analyzed by
hybridization to microarrays (Filgen Array Human35k, oligo
DNA microarray).
Statistical Analysis
Data are reported as means6standard errors, where appropri-
ate. The statistical significance (p,0.05) was determined by
Student’s t test/Mann-Whitney’s U test.
Nucleotide Sequence Accession Number
The nucleotide sequence data reported in this paper will appear
in the DDBJ/EMBL/GENBANK nucleotide sequence databases
with the accession number AB434485.
Supporting Information
Figure S1 Cluster of up-regulated genes. Microarray analysis
was performed using total RNA extracted from HUVECs treated
with Haemangin for 48 h. The total numbers of genes filtered to
include only those with "2.0 fold up-regulated compared with
untreated control are categorized according to their molecular
functions and are indicated with their relative numbers.
Found at: doi:10.1371/journal.ppat.1000497.s001 (0.05 MB PDF)
Figure S2 Cluster of down-regulated genes. Total RNA was
extracted from HUVECs treated with Haemangin for 48 h and
was subjected to microarray analysis. The "2.0 fold down-
regulated genes compared with untreated control are categorized
according to their molecular functions and are indicated with their
relative numbers.
Found at: doi:10.1371/journal.ppat.1000497.s002 (0.03 MB PDF)
Table S1 Haemangin-induced up-regulated genes ordered into
different biological processes. Transcripts were filtered to include
only those with "2.0 fold changes compared with untreated
control.
Found at: doi:10.1371/journal.ppat.1000497.s003 (0.10 MB PDF)
Table S2 Haemangin-induced down-regulated genes ordered
into different biological processes. Transcripts were filtered to
include only those with "2.0 fold changes compared with
untreated control.
Found at: doi:10.1371/journal.ppat.1000497.s004 (0.08 MB PDF)
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